T cells are collected from the patient through a process called leukapheresis. These cells are then genetically modified using viral vectors to express the chimeric antigen receptor. The CAR construct typically includes an extracellular antigen-binding domain, a transmembrane domain, and intracellular signaling domains that activate the T cell upon binding to the target antigen.
